Peer mentoring program through a digital platform for people with systemic sclerosis: A feasibility study.

Yen T Chen, Nirali Shah, Mary Alore, Sheri Hicks, Nadia Vann, Stephanie Hotz, Adam Pape, Maya Sabbagh, Melissa Cunningham, Dinesh Khanna, Susan L Murphy
{"title":"Peer mentoring program through a digital platform for people with systemic sclerosis: A feasibility study.","authors":"Yen T Chen, Nirali Shah, Mary Alore, Sheri Hicks, Nadia Vann, Stephanie Hotz, Adam Pape, Maya Sabbagh, Melissa Cunningham, Dinesh Khanna, Susan L Murphy","doi":"10.1177/23971983241295911","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>People with systemic sclerosis (SSc or scleroderma), a rare chronic autoimmune disease, often face significant physical and emotional challenges. Peer mentoring, where someone with similar lived experiences offers guidance and support, shows promise in enhancing the well-being of recipients and may benefit individuals with systemic sclerosis. This study aims to evaluate the feasibility and potential health effects of peer mentoring through a digital platform for people with systemic sclerosis.</p><p><strong>Methods: </strong>We conducted a one-group study to evaluate a 16-week peer mentoring program for people with systemic sclerosis. Mentors and mentees were matched by demographics and systemic sclerosis characteristics. Feasibility was evaluated using Orsmond and Cohn criteria: recruitment, data collection, acceptability, available resources, and participant responses to the program. Perceptions and usability of the peer mentoring program through a digital platform were assessed at week 16 (post-program). The health effects of peer mentoring were measured at baseline, week 8, and week 16.</p><p><strong>Results: </strong>Five trained mentors and 15 mentees were enrolled. Each mentor was paired with 2-4 mentees. We found that peer mentoring through a digital platform was feasible, acceptable, and had good usability for both mentors and mentees. Mentees reported significantly less anxiety at week 16 (<i>p</i> < 0.001). Other improvements in fatigue, pain interference, depressed mood, and resilience were observed, but did not reach statistical significance.</p><p><strong>Conclusion: </strong>The peer mentoring program through a digital platform was well-received. Results provided preliminary support for the feasibility and potential health benefits of peer mentoring to enhance well-being in people with systemic sclerosis. Findings lay the groundwork for future peer mentoring research in systemic sclerosis.</p>","PeriodicalId":17036,"journal":{"name":"Journal of Scleroderma and Related Disorders","volume":" ","pages":"23971983241295911"},"PeriodicalIF":1.4000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559892/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Scleroderma and Related Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23971983241295911","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: People with systemic sclerosis (SSc or scleroderma), a rare chronic autoimmune disease, often face significant physical and emotional challenges. Peer mentoring, where someone with similar lived experiences offers guidance and support, shows promise in enhancing the well-being of recipients and may benefit individuals with systemic sclerosis. This study aims to evaluate the feasibility and potential health effects of peer mentoring through a digital platform for people with systemic sclerosis.

Methods: We conducted a one-group study to evaluate a 16-week peer mentoring program for people with systemic sclerosis. Mentors and mentees were matched by demographics and systemic sclerosis characteristics. Feasibility was evaluated using Orsmond and Cohn criteria: recruitment, data collection, acceptability, available resources, and participant responses to the program. Perceptions and usability of the peer mentoring program through a digital platform were assessed at week 16 (post-program). The health effects of peer mentoring were measured at baseline, week 8, and week 16.

Results: Five trained mentors and 15 mentees were enrolled. Each mentor was paired with 2-4 mentees. We found that peer mentoring through a digital platform was feasible, acceptable, and had good usability for both mentors and mentees. Mentees reported significantly less anxiety at week 16 (p < 0.001). Other improvements in fatigue, pain interference, depressed mood, and resilience were observed, but did not reach statistical significance.

Conclusion: The peer mentoring program through a digital platform was well-received. Results provided preliminary support for the feasibility and potential health benefits of peer mentoring to enhance well-being in people with systemic sclerosis. Findings lay the groundwork for future peer mentoring research in systemic sclerosis.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过数字平台为系统性硬化症患者提供同伴指导计划:可行性研究。
目的:系统性硬化症(SSc 或硬皮病)是一种罕见的慢性自身免疫性疾病,患者通常面临着巨大的身体和情感挑战。同伴指导,即有类似生活经历的人提供指导和支持,有望提高受助者的幸福感,并可能使系统性硬化症患者受益。本研究旨在评估通过数字平台为系统性硬化症患者提供同伴指导的可行性和潜在健康影响:我们进行了一项单组研究,以评估针对系统性硬化症患者的为期 16 周的同伴指导计划。指导者和被指导者根据人口统计学特征和系统性硬化症特征进行匹配。研究采用 Orsmond 和 Cohn 标准对项目的可行性进行了评估:招募、数据收集、可接受性、可用资源以及参与者对项目的反应。在第 16 周(计划结束后),通过数字平台对同伴指导计划的认知度和可用性进行了评估。在基线、第 8 周和第 16 周对同伴指导对健康的影响进行了测量:结果:5 名经过培训的指导者和 15 名被指导者参加了该计划。结果:5 名经过培训的指导者和 15 名被指导者参加了计划,每名指导者与 2-4 名被指导者配对。我们发现,通过数字平台进行同伴指导是可行的、可接受的,而且对指导者和被指导者来说都具有良好的可用性。被指导者在第 16 周时的焦虑感明显降低(p 结论:被指导者在第 16 周时的焦虑感明显降低:通过数字平台开展的同伴指导计划广受欢迎。研究结果初步证明了同伴指导在提高系统性硬化症患者健康水平方面的可行性和潜在益处。研究结果为今后系统性硬化症的同伴指导研究奠定了基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
31
期刊最新文献
Peer mentoring program through a digital platform for people with systemic sclerosis: A feasibility study. Skin ultrasound for rheumatologists: Technical issues and challenges. What are Juvenile-onset systemic sclerosis providers thoughts, experiences, and reasons for autologous stem cell transplant? Result of a multinational survey. A Phase II study of avenciguat, a novel soluble guanylate cyclase activator, in patients with systemic sclerosis: Study design and rationale of the VITALISScE™ study. Design of CONQUEST, a novel, randomized, placebo-controlled, Phase 2b platform clinical trial to investigate new treatments for patients with early active systemic sclerosis with interstitial lung disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1